William Aird: Developing Patient-Facing Educational Material for The Blood Project
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“We have been developing patient-facing educational material for The Blood Project, and one recurring theme is that common hematologic findings are often not dangerous, but they are often poorly explained.
Thalassemia trait is a good example.
Many patients are told they ‘have thalassemia’ without a clear explanation of what that means.
They may worry that they have a serious blood disease, that they will become ill, or that they need treatment.
It is common.
It is usually benign.
And it is often poorly explained.
Thalassemia trait is not a disease in the usual sense.
It is a common inherited hemoglobin variant, found at high frequency in parts of the world where malaria has exerted powerful evolutionary pressure.
For the individual carrier, it may cause small red blood cells and sometimes mild anemia, but it usually does not cause symptoms or require treatment.
What it does require is explanation.
Patients need to know:
- this is inherited, not acquired
- it is not iron deficiency
- iron should not be given unless iron deficiency is actually present
- family planning may matter if a partner also carries a hemoglobin variant
- the CBC may look ‘abnormal’ even when the patient is well
In other words, the problem is often not the trait.
The problem is the explanation.
We created this short patient-facing guide for The Blood Project to help clinicians and patients have a clearer conversation.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 16:23Antonio Paul: When a Low Platelet Count Does Not Mean Weak Clotting
-
Sep 10, 2026, 16:12Balancing Thrombosis and Bleeding in Antiphospholipid Syndrome
-
Sep 10, 2026, 16:07Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
-
Sep 10, 2026, 16:04Isaac Okello: Where Skyline Meets Savannah – Quiet Moments at GASCDO in Nairobi
-
Sep 10, 2026, 15:58Joyisa Deb: How Immune Recognition Reshapes Clinical Practice
-
Sep 10, 2026, 15:56Alexsander Santiago: When Was Your ECMO Anticoagulation Target Last Challenged?
-
Sep 10, 2026, 15:51Christopher Bocquet: A Call for Feedback on the Proposed 13th Edition of Standards for Biotherapy Services
-
Sep 10, 2026, 15:45Amos Gitonga Mbaabu: GASCDO Conference in Nairobi – Translating Sickle Cell Innovations into Equitable Care
-
Sep 10, 2026, 15:36Majdouline El Moussaoui: What If AA Amyloidosis is the First Clue to an Undiagnosed Monogenic Autoinflammatory Disease?